Diabetic cardiovascular autonomic neuropathy, a silent risk factor for general anesthesia and outcome; prevalence, diagnostics and perioperative care

Diabetic cardiovascular autonomic neuropathy, a silent risk factor for general anesthesia and outcome; prevalence, diagnostics and perioperative care - CAN study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33612

Enrollment

Registered

2009-04-02

Start date

2009-06-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

algehele anesthesie Diabetes Mellitus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Diabetes mellitus, type II * Age between 40*75 years * Scheduled for surgery * Informed consent

Exclusion criteria

Exclusion criteria: * Known/documented cardiac disease * Use of medication for hypertension * Abnormal ECG or echocardiogram * Peripheral vascular disease * Renal disease requiring hemo- or peritoneal dialysis

Design outcomes

Primary

Measure	Time frame
* Consistency in the results of the autonomic function tests at the outpatient preoperative screening clinic and the official autonomic function test laboratory. * The correlation between CAN and intra- and postoperative hemodynamic- and autonomic instability	—

Secondary

Measure	Time frame
* The prevalence of CAN in patients with diabetes at the preoperative outpatient screening clinic diagnosed by analysis of patient files. * Demographic patient variables: age, sex, weight, length, comorbidities.	—

Countries

Netherlands

Outcome results